The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Minimal residual disease (MRD) monitoring by multiparameter flow cytometry (MFC) in newly diagnosed transplant eligible multiple myeloma (MM) patients: Results from the EMN02/HO95 phase 3 trial.
 
Stefania Oliva
Honoraria - Celgene; Takeda
 
Davine Hofste op Bruinink
No Relationships to Disclose
 
Lucie ŘÍhová
No Relationships to Disclose
 
Stefano Spada
No Relationships to Disclose
 
Bronno van der Holt
No Relationships to Disclose
 
Rossella Troia
No Relationships to Disclose
 
Manuela Gambella
No Relationships to Disclose
 
Lucia Pantani
No Relationships to Disclose
 
Sara Grammatico
No Relationships to Disclose
 
Milena Gilestro
No Relationships to Disclose
 
Massimo Offidani
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
 
Rossella Ribolla
No Relationships to Disclose
 
Monica Galli
No Relationships to Disclose
 
Roman Hajek
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Takeda
 
Antonio Palumbo
Employment - Takeda
Honoraria - Genmab; Janssen-Cilag; Takeda
Consulting or Advisory Role - Genmab; Janssen-Cilag; Takeda
Research Funding - Genmab (Inst); Janssen-Cilag (Inst); Takeda (Inst)
 
Michele Cavo
No Relationships to Disclose
 
Paola Omedè
No Relationships to Disclose
 
Vincent van der Velden
No Relationships to Disclose
 
Mario Boccadoro
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Mundipharma; Novartis; Sanofi
 
Pieter Sonneveld
Honoraria - Amgen; Celgene; Janssen-Cilag; Karyopharm Therapeutics
Research Funding - Amgen; Celgene; Janssen-Cilag; Karyopharm Therapeutics